Evaluation of The Clinical Potential in Prostate Cancer Using Maintrac®

Loading Events

« All Events

Evaluation of The Clinical Potential in Prostate Cancer Using Maintrac®

December 2 @ 7:00 pm - 8:00 pm
Free

Evaluation of The Clinical Potential in Prostate Cancer Using Maintrac®

Exploring the use of circulating epithelial tumour cell tracking (CETCs) to inform personalised and integrative approaches in cancer support

***

DESCRIPTION

Prostate cancer remains the most common cancer among men, with risk increasing significantly with age. Many cases involve slow-growing, less aggressive tumours that can develop slowly over a period of many years. To help avoid overtreatment in these low-risk patients, “active monitoring” and “watch-and-wait” approaches are often adopted, allowing for careful observation over time.

For practitioners supporting clients with a diagnosis of prostate cancer, gaining reliable insights into tumour behaviour without invasive procedures can be invaluable. Maintrac®, a liquid biopsy method, offers a new dimension of understanding, enabling tumour activity to be assessed directly without the need for invasive interventions or imaging. In more advanced cases, Stemtrac® can also be used to track circulating stem cells, offering additional information on tumour cell behaviour.

In this upcoming webinar, Professor Katharina Pachmann, a pioneer in the field of liquid biopsy and circulating tumour cell (CTC) analysis, will present how Maintrac® and Stemtrac® technologies are transforming the monitoring and management of prostate cancer, including how effective therapeutic approaches are likely to be. She will also present their latest scientific study exploring the role of Maintrac® during radiotherapy, and how these innovative methods can contribute to optimising therapy decisions.

Professor Katharina Pachmann will also discuss the analysis of key therapy-relevant biomarkers on circulating tumour cells, including Prostate-Specific Antigen (PSA), Prostate-Specific Membrane Antigen (PSMA), the Androgen Receptor (AR), and B7-H3.

***

ABOUT THE SPEAKER

Professor Dr. med. Katharina Pachmann runs the Maintrac laboratory in Bayreuth, Germany, together with Dr. Ulrich Pachmann and a team of 45. As both a medical doctor and research scientist, she has been conducting studies in this field and refining related techniques for over two decades, and has authored over a hundred peer-reviewed scientific publications on the technique.

Details

Venue

Organiser

  • Academy of Nutritional Medicine (AONM)
  • Email info@aonm.org